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Two genes, bshA and bshB, encoding bile salt hydrolase enzymes (EC 3.5.1.24) were identiﬁed in the genome
sequence of Lactobacillus acidophilus NCFM. Targeted inactivation of these genes via chromosomal insertion of
an integration vector demonstrated different substrate speciﬁcities for these two enzymes.
In humans and other mammals, primary bile salts are pro
duced de novo in the liver from cholesterol (4). The steroid
portion of the molecule is conjugated with an amide bond at
the C-24 position to one of two amino acids, taurine or glycine.
Following manufacture, conjugated bile salts are stored in the
gall bladder and secreted via the bile duct into the small in
testine. Here, these conjugates form spontaneous micelles that
trap dietary cholesterol and fats, thus facilitating their absorp
tion by the intestinal epithelium into the bloodstream (25).
While more than 95% of bile salts enter the enterohepatic
circulation in humans (17), up to 650 mg of bile salts per day
elude absorption through the intestinal epithelium. Thus, high
concentrations of these conjugates are present in the gastro
intestinal tract.
Certain species of the indigenous microﬂora, including a
number of lactobacilli and biﬁdobacteria, have evolved the
ability to deconjugate bile salts. This action is dependent on
the presence of an enzyme known as bile salt hydrolase (BSH;
cholylglycine hydrolase; EC 3.5.1.24) that catalyzes the hydro
lysis of glycine- and/or taurine-conjugated bile salts into the
amino acid residue and the bile acid (13). Several theories have
been proposed for the ecological signiﬁcance of BSH activity in
these organisms. These include their ability to use free amino
acids as electron acceptors to obtain energy under anaerobic
conditions (19, 35) and self-protection against the toxic effects
of bile salts (32). However, studies on the impact of BSHproducing organisms in the colonized host have produced
much conﬂicting evidence. Observations that a reduction in the
levels of serum cholesterol is associated with the presence of
BSH-producing organisms has led to increased interest in the
possibility of their use in hypercholesterolemic individuals or
to prevent elevated cholesterol levels in individuals with nor
mal cholesterol status (8). Conversely, negative effects have
also been reported including cases of contaminated small
bowel syndrome, impaired lipid absorption, gallstone forma
tion, and increased risk of colon cancer (25).
Lactobacillus acidophilus NCFM is a human isolate used

commercially for over 25 years as a probiotic culture (31). The
organism has the ability to survive in the gastrointestinal tract
(31, 33), adhere to human epithelial cells in vitro (16), utilize
fructooligosaccharides (3), modulate the host immune re
sponse, and prevent microbial gastroenteritis (36). Analysis of
the NCFM genome sequence revealed the presence of two
putative bile salt hydrolase genes (2). The bile-hydrolyzing
capability associated with L. acidophilus NCFM had been pre
viously identiﬁed by phenotypic screen (D.C. Walker, unpub
lished results). Due to the implications of the presence of bile
salt hydrolase in several probiotic strains, this study was de
signed to further characterize this activity in NCFM through
targeted gene inactivation.
Genomic analysis of the bsh loci. To identify the molecular
foundations of the relationship between probiotic organisms
and their hosts, genetic characterization of strains is essential
(26). Thus, L. acidophilus NCFM was chosen for whole-ge
nome sequencing. The 2.0-Mb genome sequence of L. aci
dophilus NCFM has recently been elucidated (2) and contains
1,864 predicted protein-encoding genes. Sequence analysis was
performed using a combination of GCG (version 9.1; Univer
sity of Wisconsin Genetics Computer Group), Clone Manager
(version 6.0; SciEd Central) and GAMOLA (1). Protein ho
mology searches were performed with the Basic Local Align
ment Search Tool (PSI-BLAST), version 2.2, at the website of
the National Center for Biotechnology Information (http:
//www.ncbi.nlm.nih.gov). Screening of early drafts of the ge
nome sequence led to the identiﬁcation of an open reading
frame (ORF) whose predicted protein sequence showed sig
niﬁcant similarity to BSH enzymes found in a number of other
organisms (Table 1). These included Lactobacillus johnsonii
(82%) (29), Listeria monocytogenes (65%) (9), and Biﬁdobac
terium longum (54%) (34). This gene was designated bshA.
Analysis of the genomic organization of the region surround
ing bshA revealed the presence of a number of ORFs with
homology to DNA helicases, transporters, and hypothetical
proteins (Fig. 1). A promoter-type structure and ribosomal
binding site preceding bshA were identiﬁed, as well as a puta
tive terminator (lG = -24.7 kcal) downstream, suggesting
that bshA is transcribed independently of the surrounding
genes. Subsequent sequencing, leading to improved genome
assemblies, resulted in the identiﬁcation of another ORF, des

TABLE 1. Comparison of amino acid sequences of some bacterial BSH enzymes
BshA
Bacterial strain/peptide

NCFM BshA
L. johnsonii NCC533 (1147)
Lactobacillus gasseri ADH
L. gasseri
L. johnsonii NCC533 (1412)
L. johnsonii 100-100 alpha
Enterococcus faecium FAIR-E 345
L. monocytogenes EGD-e
E. faecalis V583
Lactobacillus plantarum WCFS1
L. plantarum 80
Clostridium perfringens
B. longum SBT2928
L. johnsonii 100-100 beta
Biﬁdobacterium biﬁdum ATCC11863
L. acidophilus KS-13
a

BshB

Reference(s)a

Accession no.

CP000033
NC_005362
AAK07837
ZP_00046418
NC_005362
AAG22541
AY260046
NP_465591
NC_004668
NC_004567
Q06115
NP_561625
AAF67801
AAC34381
AY506536
AAD03709

% Identity

% Similarity

% Identity

% Similarity

100
69
65
65
61
61
50
47
49
46
46
37
35
35
34
34

100
82
77
77
79
79
67
65
68
65
64
56
54
52
55
51

57
55
56
57
57
57
57
56
55
52
52
38
37
33
37
32

57
72
73
73
76
76
73
74
73
71
71
56
54
54
55
53

2
29
30
DS*
29
10, 11
DS*
9
28
23
7
5
34
10, 24
22
DS*

*, direct submission to the National Center for Biotechnology Information.

ignated bshB, the putative gene product of which displayed
57% identity to that of bshA. Again, a ribosomal binding site
and putative promoter were identiﬁed within the genome
structure; a potential terminator (lG = -21.4 kcal) down
stream also indicates that bshB is most likely to be monocis
tronic. Genes in the vicinity of bshB were predominantly sim
ilar to genes encoding hypothetical proteins of unknown
function (Fig. 1). No other bsh homologues were found in the
L. acidophilus NCFM genome. The GenBank accession num
ber for the L. acidophilus NCFM genome sequence from which
the bshA and bshB genes are derived is CP000033.
Construction of bsh mutants. The directed integration sys
tem described previously by Russell and Klaenhammer (30)
was used to inactivate ﬁrst bshA and then bshB in the genome
of L. acidophilus NCFM, creating two separate mutants. Prim
ers were designed to amplify a 588-bp internal region of bshA
(forward primer, 5'-AAA GTC GAC GAA AAG GGG CTT
GGT A-3'; reverse primer, 5'-AAG AAT TCC CAT CAG
GTT GTT CTA C-3'). The underlined restriction sites were
used to clone the ampliﬁed product into the Ori+ RepAintegration plasmid, pORI28. The resultant plasmid,

pTRK734, was transformed into L. acidophilus NCFM con
taining pTRK669, a temperature-sensitive helper plasmid that
provides repA in trans for the replication of pORI28. A tem
perature increase from 37°C to 42°C resulted in the integration
of pTRK734 into the NCFM genome, concurrent with the loss
of pTRK669 and its associated Cmr phenotype at the nonper
missive temperature. To conﬁrm the integration of pTRK734
at the correct genome locus, Southern hybridizations were
performed using the 588-bp fragment, labeled with nonradio
active digoxigenin (DIG) (Roche Diagnostics Corporation, In
dianapolis, IN), as a probe. The bshA probe hybridized to a
4.8-kb EcoRI fragment in the wild type (Fig. 2A). In the mu
tant NCFMlbshA (or NCK1618), this band was absent, and
due to the presence of a single EcoRI site in the integration
vector sequence, junction fragments of approximately 4.3 kb
and 2.7 kb were observed (Fig. 2A). This genome structure is
indicative of the occurrence of a single crossover homologous
recombination event (Fig. 2B). An additional band of 2.3 kb
was detected in the mutant (Fig. 2); this fragment corresponds
to the integration vector, pTRK734, which had ampliﬁed and
was present in more than one copy. In the case of bshB, a

FIG. 1. Schematic representation of the genetic organization of the bsh loci of L. acidophilus NCFM. Arrows indicate ORFs and the directions
of transcription; bsh genes are represented by solid black arrows. Annotations of ﬂanking genes are also indicated. HP denotes a hypothetical
protein of unknown function. This representation is not drawn to scale.

FIG. 2. (A) Southern hybridization analysis of L. acidophilus NCFM and NCK1618. Chromosomal DNA was digested with EcoRI (lanes 1 and
2) and hybridized with the DIG-labeled 588-bp internal bshA fragment as a probe. Lanes: M, DIG-labeled A-HindIII marker (Roche Molecular
Biochemicals); 1, NCFM; 2, NCK1618. DNA sizes are indicated in kilobases. (B) Schematic representation of the relevant regions of the NCFM
and NCFMlbshA (NCK1618) chromosomes. Heavy lines represent chromosomal DNA; thin lines represent plasmid DNA. bshA is represented
by the arrow, and the shaded box is the internal fragment corresponding to the hybridization probe. EcoRI sites (E) are indicated.

618-bp internal fragment was ampliﬁed (forward primer, 5'
AGG ATC CAG TTA GTT CCA TCA GAA TA-3'; reverse
primer, 5'-TAT AAG CTT GGT ATG GCC GGA CTC AAC
3') and cloned into pORI28 to create pTRK735 and a similar
strategy adopted for inactivation. The integration event was
checked and veriﬁed in a manner similar to that shown in Fig.
2 for the bshA mutant. The bshB mutant was designated
NCFMlbshB (or NCK1619).
Determination of bile tolerance. Bile tolerance is an impor
tant criterion in the selection of probiotic strains. Previous
reports have suggested that a concentration of 0.3% oxgall
(Sigma Chemical Co., St. Louis, MO) closely approximates the
bile levels found in the gastrointestinal tract (14, 15). To eval
uate their ability to grow in the presence of bile, the parent,
NCFMlbshA, and NCFMlbshB were screened for growth on
MRS plates or in MRS broth supplemented with concentra
tions of oxgall up to 0.5%. Typically, Lactobacillus spp. do not
grow at levels higher than 0.3% (20, 21). When incubated
under anaerobic conditions, the parent was capable of growth

in up to 0.25% oxgall, as were both NCFMlbshA and
NCFMlbshB (data not shown). At concentrations of 0.3% and
higher, no growth was observed for any strain, either in broth
or on plates. This indicated that inactivation of one or other of
the bile salt hydrolase enzymes of L. acidophilus NCFM did
not affect its ability to grow in the presence of bile.
Detection of BSH activity. A direct plate assay for detection
of BSH activity was employed to compare the NCFMlbshA
and NCFMlbshB mutants with the wild-type strain. A number
of glycine- and taurine-conjugated bile salts were selected for
the assays; these are listed in Table 2. By the inclusion of bile
salts in agar medium, BSH-positive strains can be identiﬁed by
halos of precipitated free bile acids surrounding the colonies
due to hydrolysis and acidiﬁcation of the medium. The assay
used in this study is a modiﬁed version of that developed by
Dashkevicz and Feighner (6); in our assays, the upper concen
tration of bile salts used was reduced from 0.5% to 0.2% due
to the inability of L. acidophilus NCFM to grow at 0.5%. In the
cases of taurochenodeoxycholic acid (TCDCA) and glycoche-

TABLE 2. Analysis of L. acidophilus NCFM and bsh mutants on different bile saltsa
Value (%) for indicated strain
b

NCFM

Bile salts (%)

TDCA (0.2)
TCA (0.2)
TCDCA (0.05)
TCDCA (0.02)
GDCA (0.2)
GCA (0.2)
GCDCA (0.05)
GCDCA (0.02)

NCFMlbshA

NCFMlbshB

Growth

Precipitation

Growth

Precipitation

Growth

Precipitation

100
100
100
100
60
100
30
30

100
60
100
100
60
100
30
30

100
100
100
100
60
100
30
30

100
60
0
5
60
100
0
5

100
100
5
5
60
100
30
30

0
0
0
0
60
100
30
30

a
Numeric values represent an arbitrary scoring system; levels of growth and precipitation are scored relative to NCFM on 0.2% TDCA, which is given a score of
100%.
b
GDCA, glycodeoxycholic acid; GCA, glycocholic acid.

FIG. 3. Plate assays for the detection of BSH activity. (A) L. acidophilus NCFM; (B) NCFMlbshA (NCK1618); (C) NCFMlbshB (NCK1619)
on MRS agar containing 0.2% TDCA. In the assays shown, precipitation in the agar is indicative of BSH activity speciﬁc for TDCA.

nodeoxycholic acid (GCDCA), this concentration was reduced
further to 0.02 to 0.05%. For the wild-type strain, hydrolysis of
taurodeoxycholic acid (TDCA) (Table 2 and Fig. 3A) and
taurocholic acid (TCA) (Table 2) under anaerobic conditions
resulted in signiﬁcant amounts of deoxycholic acid precipitat
ing around active colonies. Similar levels of precipitation were
observed surrounding colonies of NCFMlbshA when plated
on TDCA (Table 2 and Fig. 3B) and TCA (Table 2), indicating
that this mutant had retained the ability to hydrolyze these
deoxy-conjugated compounds. Furthermore, NCFMlbshA re
tained the ability to hydrolyze the glycine-conjugated com
pounds such as glycodeoxycholic acid and glycocholic acid.
Hydrolysis of TCDCA and GCDCA by L. acidophilus NCFM
was observed as a cloudiness in the agar rather than as distinct
zones of precipitation observed for the other bile salts. How
ever, while both the parent and mutant grew, albeit slowly, on
0.05% TCDCA and GCDCA, NCFMlbshA appeared to have
lost the ability to hydrolyze both salts (Table 2), as indicated by
the lack of precipitation in the agar. Interestingly, when both
TCDCA and GCDCA concentrations in the agar were further
reduced to 0.02%, NCFMlbshA showed some signs of BSH
activity (Table 2). The creation of a lbshB mutant allowed the
activities of BshB to be assessed in a similar manner. Compar
isons with the parent strain demonstrated that while
NCFMlbshB displayed growth on and precipitation of all gly
coconjugates tested, this mutant was capable of growth but
incapable of precipitation of the tauroconjugated bile salts,
TCA, TDCA, and TCDCA (Table 2 and Fig. 3C).
Thus, to summarize, while NCFMlbshA was capable of
the hydrolysis of some tauro- and glycoconjugated bile salts,
this mutant had a reduced ability to hydrolyze TCDCA and
GCDCA, bile salts containing chenodeoxycholic acid as the
steroid moiety. Conversely, inactivation of bshB revealed that
the BshB enzyme encoded by this gene appears to exhibit
substrate speciﬁcity dictated by the amino acid conjugated to
the bile salt. This conclusion was made based on the inability of
NCFMlbshB to hydrolyze any bile salt conjugated to taurine.
Previous studies have demonstrated that the speciﬁcity of the
catalytic activities of BSH enzymes may be inﬂuenced either by
the amino acid in the conjugate or by other side chains in the
steroid moiety (13, 18, 27). Our results suggest that BshA
activity is dictated by the steroid nucleus of the conjugated bile
salt, while the speciﬁcity of BshB is determined by the presence
of taurine in the bile salt structure.

To our knowledge, this is the ﬁrst report of the presence of
two BSH enzymes with different substrate speciﬁcities in a
single strain of Lactobacillus. Although BSH production is not
an essential attribute for organisms that colonize the gastroin
testinal tract, its importance in colonizing species of Lactoba
cillus is highlighted by the high level of conservation between
the various enzymes indicated in Table 1. However, after a
comparison of both predicted protein sequences to the de
duced amino acid sequences of other BSH enzymes, it was
interesting that they both share a higher level of identity to
enzymes from other Lactobacillus species than to each other.
BshA shares 69% identity with the enzyme from L. johnsonii
NCC533 (29), while BshB is more similar (57% identity; 76%
similarity) to that of BSH alpha from L. johnsonii 100-100 (11).
No such identity was observed at the DNA level. However, the
G+C contents of both genes are similar to those of other genes
in the L. acidophilus NCFM genome. Therefore, it is possible
that bshA and bshB may have originated from different sources
through horizontal gene transfer from a closely related ge
nome, but we have no tangible evidence for this at the present
time. Another possibility is that these genes may have arisen
from a duplication event, following which the genes have sub
sequently diverged to encode enzymes with different substrate
speciﬁcities. However, since the proteins share only 57% iden
tity, this scenario is unlikely.
While the evolution of BSH enzymes with different activities
in L. acidophilus NCFM is striking, the signiﬁcance of BSH
activity in lactobacilli is still far from understood. Since the free
bile acids appear to be more inhibitory than the conjugated
bile salts themselves, it is most likely not a detoxiﬁcation mech
anism for these organisms. While some positive effects of the
consumption of BSH-producing probiotics have been docu
mented, the effects are often transient and unsustainable. Gen
erally, human studies have yielded mixed results with no clearcut reduction in cholesterol observed due to probiotic
consumption (12). It seems that the debate will continue as to
whether or not this enzyme activity is a desirable property in
probiotic bacteria.
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